Schriftgröße:

Veröffentlichungen

Prof.-Dr.-med
I. Originalarbeiten

  1. Rinnab L, Winckelmann HJ: The life and works of Professor Max Hösel (1906-1971): A pioneer of endoscopic prostate surgery. Urologe A. 2014 Dez; 53 (12): 1822-32
  2. Schnoeller T, Jentzmik F, Rinnab L, Cronauer MV, Damjanoski I, Zengerling F, Ghazal AA, Schrader M, Schrader AJ.:Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer. World J Urol. 2013 Apr;31(2):253-9
  3. Damjanoski I, Müller J, Schnöller TJ, Küfer R, Rinnab L: [Histopathology reports of findings of prostate needle biopsies. Individual treatment]. Urologe A. 2013 Feb;52(2):226-39
  4. Zengerling F, Schrader AJ, Cronauer MV, Stemann H, Schrader M, Rinnab L: The „Aging Males‘ Symptoms“ Scale (AMS): predictive value for lowered circulating androgens. Aging Male. 2012 Dec;15(4):253-7
  5. Schnöller TJ, Jentzmik F, Al Ghazal A, Zengerling F, de Petriconi R, Hefty R, Rinnab L, Schrader M, Schrader AJ.[Renal masses in pregnancy. Diagnostics and therapeutic management]. Urologe A. 2011 Sep;50(9):1064-7
  6. Rinnab L: Emergency checklist: acute scrotum. MMW Fortschr Med. 2011 Mar 31;153(13): 41.
  7. Schütz SV, Cronauer MV, Rinnab L: Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines. Schütz SV, Cronauer MV, Rinnab L, J Cell Biochem. 2010 Apr 15;109(6):1192-200
  8. Rinnab L, Simon J, Hautmann RE, Cronauer MV, Hohl K, Buck AK, Reske SN, Mottaghy FM: [11C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy. World J Urol 2009 Oct, 27(5):619-625
  9. Simon J, Bartsch G Jr., Rinnab L, Hautmann RE, Volkmer BG: Transrectal ultrasound as diagnostic tool for detection of local recurrence following cystectomy and urinary diversion. Urol Int. 2009; 82(1):12-16
  10. Gust K, Engel O, Schertl U, Kuefer R, Rinnab L: Clinical significance of postoperative lymphoceles following pelvic node dissection in prostate cancer disease. Int J Nephrol Urol, 2009;1(2):94-102
  11. Gust KM, Hofer MD, Perner SR, Kim R, Chinnaiyan AM, Varambally S, Moeller P,
    Rinnab L, Rubin MA, Greiner J, Schmitt M, Kuefer R, Ringhofer M: RHAMM (CD 168) is overexpressed at the protein level and may contribute an immunogenic antigen in advanced prostate cancer disease. Neoplasia 2009; 11(9):956-63
  12. Rinnab L: Histopathologische Befundberichte von Prostatastanzbiopsien: Welche Informationen benötigen Urologen, um individuelle Behandlungsentscheidungen treffen zu können? Eingeladener Beitrag zum Kongressheft DGU 2009 im Rahmen eines Sonderheftes
  13. Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study.Böhle A, Leyh H, Frei C, Kühn M, Tschada R, Pottek T, Wagner W, Knispel HH, von Pokrzywnitzki W, Zorlu F, Helsberg K, Lübben B, Soldatenkova V, Stoffregen C, Büttner H; S274 Study Group. Collaborators (23): Renner P, Weinknecht S, Musch M, Bagner JW, Szlaby T, Schneider A, Pape D, Gschwend J, Rinnab L, Schönfelder R, Ciorobea A, Golinski C, Scheidweiler U, Koser MF, Häcker M, Steiner T, Herbst U, Michel MS, Röpke A, Petrisch O, Ozen H, Kuyumcuoglu U, Tansug Z. Eur Urol. 2009 Sep;56(3):495-503
  14. Rinnab L, Schütz S.V, Diesch J, Schmid E, Küfer R, Hautmann RE, Spindler KD, Cronauer MV. Inhibition of Glycogen-Synthase Kinase-3 (GSK) in Androgen Responsive Prostate Cancer Cell Lines – Are GSK-Inhibitors Therapeutically Useful? Neoplasia Jun 2008, 10(6):624-633
  15. Simon J, de Petriconi R, Rinnab L, Hautmann RE, Kurtz F. Optimizing Selective Renal Clamping in Nephron-Sparing Surgery Using the Nussbaum Clamp. Urology 2008 Jun, 71(6):1196-8
  16. Merseburger AS, Hennenlotter J, Stenzl A, Beger G, Rinnab L, Kuczyk MA, Kuefer R. Cathepsin D serum levels are not a valid serum marker in renal cell carcinoma. Urol Int. 2007; 79(1):41-3
  17. Prowald A, Cronauer MV, von Kloth C, Eilers T, Rinnab L, Herrmann Thomas, Spindler KD, Montenarh M, Jonas U, Burchardt M. Modulation of ß-Catenin-Mediated TCF-Signalling in Prostate Cancer Cell Lines by Wild-Type and Mutant p53. Prostate 2007, Dez 1; 67(16): 1751-60
  18. Rinnab L, Mottaghy FM, Simon J, Volkmer B, Petriconi R, Hautmann RE, Wittbrodt M, Egghart G, Moeller P, Blumstein NM, Reske S, Kuefer R. [11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer – preliminary results of a prospective study – Accepted for Publication in Urol Int
  19. Finter F, Rinnab L, Simon J, Volkmer B, Hautmann R, Kuefer R: Ureteral stricture after extracorporeal shock wave lithotripsy: Case report and overview of the spectrum of rare side effects of modern ESWL treatment. Urologe A Jul 2007; 46(7):769-72
  20. Kuefer R, Genze F, Zugmaier W, Hautmann RE, Rinnab L, Gschwend JE, Angelmeier M, Estrada A, Buechele B: Antagonistic Effects of Sodium Butyrate and N-(Hydroxyphenyl)-retinamide on Prostate Cancer. Neoplasia 2007 Mar; 9(3):246-53
  21. Rinnab L, Blumstein NM, Mottaghy FM, Kuefer R, Hautmann RE, Kathrin Hohl, Sven N. Reske: [11C]choline-PET/CT Imaging and Transrectal ultrasonography for staging of localized prostate cancer. BJU international 2007 Jun; 99(6):1221-6
  22. Rinnab L, Mottaghy FM, Blumstein NM, Reske SN, Hautmann RE, Hohl K, Küfer R*, Gschwend JE*: Evaluation of [11C]choline-PET/CT in patients with increasing PSA after primary treatment of prostate cancer. BJU international 2007 Oct; 100(4):786-93
  23. Rinnab L, Gottfried HW, Hautmann RE, Küfer R: Clinical value of transrectal ultrasound in the diagnosis of suspected neoplasias in the small pelvis. Ultraschall in der Medizin 2007Apr; 28(2): 195 – 200
  24. Rinnab L, Küfer R, Hautmann RE, Gottfried HW: Use of TRUS-guided biopsy in the diagnosis of pelvic malignancies. Journal of Clinical Ultrasound 2006 Nov-Dec;34(9):440-5
  25. Cronauer MV, Ince Y, Engers R, Rinnab L, Weidemann W, Suschek CV, Burchard M, Kleinert H, Wiedenmann J, Sies H, Ackermann R, Kröncke KD: Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression. Oncogene 2007 Mar 22;26(13): 1875 – 1984
  26. Rinnab L, Straub M, Hautmann RE, Brändle E: Postoperative resorptive and excretory capacity of the ileal neobladder. BJU International 2005 Jun;95(9): 1289 – 92
  27. Volkmer BG, Nesslauer T, Rinnab L, Schradin T, Hautmann RE, Gottfried HW: Surgical intervention for complications of tension-free vaginal tape procedure. J Urol. 2003 Feb; 169(2): 570 – 4
  28. Stassar MJ, Devitt G, Brosius M, Rinnab L, Prang J, Schradin T, Simon J, Petersen S, Kopp-Schneider, Zoller M: Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer 2001 Nov.2; 85(9): 1372 – 82

II.Übersichtsarbeiten

  1. Rinnab L, Schrader AJ, Schrader M, Zengerling F: [Male sexuality in the elderly]. Urologe A. 2012 Oct;51(10):1399-413
  2. Rinnab L, Ringhoffer M, Mayer-Steinacker R, Hautmann RE, Simon J: Prevention, early diagnosis and treatment of chemoextravasation. Practical management in the uro-oncological practice. Urologe A. 2009 Nov; 48(11):1283-4, 1286-90, 1292-4.
  3. Finter F, Rinnab L, Gust K, Küfer R.: Palliative systemic therapy of castration-resistant prostate cancer: current developments. Urologe A. 2009 Nov;48(11):1295-30
  4. Rinnab L, Gust K, Hautmann RE, Kuefer R: Testosteronsubstitution und Prostatakarzinom – Eine Standortbestimmung 67 Jahre nach dem Huggings-Mythos. Urologe A May 2009; 48(5):516-22
    Current aspects and medication therapy strategies for out-patient uro-oncological therapy: Rinnab L, Küfer R. Urologe A 2009 Oct 22 [Epub ahead of print]
  5. Ringhoffer M, Rinnab L, Küfer R, Greiner J: Systemic therapy of metastatic renal cell carcinoma : From many options to the therapeutic strategy. Urologe A. 2009 Oct 7. [Epub ahead of print].
  6. Intravesical therapy in non-muscle-invasive bladder cancer: Indications and practical considerations. Simon J, Finter F, Schnöller T, Hautmann R, Rinnab L.
    Urologe A. 2009 Oct 2. [Epub ahead of print].
  7. Complementary medicine in oncology: Schnöller T, Küfer R, Eismann T, Rinnab L. Urologe A 2009 Oct 1 [Epub ahead of print].
  8. Rinnab L, Hessenauer A, Schütz SV, Schmid E, Finter F, Kuefer R, Hautmann RE, Spindler KD, Cronauer MV: Rolle des Androgenrezeptors im hormonrefraktären Prostatakarzinom – Molekulare Grundlagen und experimentelle Therapieansätze. Urologe A 2008 Mar; 47(3): 314-25
  9. Finter F, Mottaghy FM, Hautmann RE, Küfer R, Rinnab L: Systemic therapy approaches in patients with bone metastases of urogenital malignancies. Urologe A 2007, July 19
  10. Rinnab L, Cronauer MV, Spindler KD, Hautmann RE, Kuefer R. Forschungsaktivitäten an der Universität Ulm um das Prostatakarzinom. Urologe A 2007 Sep; 46(9):1071-1077
  11. Rinnab L, Hautmann RE, Straub M: Alkalizitrate in der Urologie. Eine Standortbestimmung. Urologe A 2004 Apr;43(4): 429-39
  12. Rinnab L, Gschwend JE, Hautmann RE, Straub M: Rationale Diagnostik der Urolithiasis in der täglichen Praxis. Deutsche Medizinische Wochenschrift 2004 Okt. 22; 129(43): 2301 – 4
  13. Rinnab L, Gschwend JE, Hautmann RE, Straub M: Rationale Therapie der Urolithiasis in der täglichen Praxis. Deutsche Medizinische Wochenschrift 2004 Okt. 29; 129(44): 2361 – 5
  14. Rinnab L, Hautmann RE, Gottfried HW, Straub M: Rationale Diagnostik und Therapie der Nierenkolik im Jahr 2005 – Was ist Neu? Zentralblatt für Chirurgie 2005 Dez; 130(6):505-13
  15. Rinnab L, Küfer R, Hautmann RE, Volkmer BG, Straub M, Blumstein NM, Gottfried HW: Innovative Diagnostik in der Früherkennung und beim Staging des lokalisierten Prostatakarzinoms. Urologe A 2005 Nov; 44(11):1262-76
  16. Straub M, Hautmann RE, Hesse A, Rinnab L: Calcium oxalate stones and hyperoxaluria. What is certain? What is new? Urologe A 2005 Nov; 44(11):1315-23
  17. Küfer R, Autenrieth M, Herkommer K, Blum P, Merseburger A, Hofer M, Rinnab L, Gschwend J, Ringhofer M: Translation molekularer Zusammenhänge in die klinische Anwendung am Beispiel des Vascular Endothelial Growth Factor (VEGF) Pathway. Urologe A 2006 Mar; 45(3):328-35

Kasuistiken

  1. Rinnab L, Schulz K, Siech M: Seltene Lokalisation eines PankreasAnulare – Pars horizontalis duodeni – kasuistische Darstellung und chirurgische Therapie. Zentralblatt für Chirurgie 2004; 129(6):513-516
  2. Rinnab L, Paiss T, Küfer R: Klippel-Trenaunay-Syndrom – Eine seltene Ursache für rezidivierende Makrohämaturie – Kasuistische Falldarstellung. Urologe A 2006 Jun;45(6): 739-741